Global Health

Current understanding

To be populated as evidence accumulates.

Evidence log

• 2021-06-30 — USAID · LVCT HEALTH — $50.0M (KEN): USAID obligated $50.0M to LVCT Health for the Kenya Health Partnerships for Quality Services (KHPQS) Cluster 1 program, adding a Kenyan implementer to the KHPQS cluster alongside Deloitte’s Tujenge Jamii and Moi Teaching and Referral Hospital’s AMPATH UZIMA. (novelty: 3)
• 2025-11-25 — State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $38.3M (CHE): State obligated $38.3M to the Global Fund to procure Lenacapavir (long-acting injectable PrEP) for PEPFAR-supported countries, extending the U.S. global-health portfolio into next-generation HIV prevention commodities via a multilateral procurement channel. (novelty: 3)
• 2021-10-04 — USAID · CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA — $37.6M (ZMB): USAID obligated $37.6M to the Centre for Infectious Disease Research in Zambia for HIV prevention service delivery, extending the global-health portfolio to a Zambian implementer. (novelty: 3)
• 2026-05-12 — State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $260.5M (CHE): 2024 — State · THE GLOBAL FUND — $260.5M (CHE) (citation removed): State obligated $260.5M to the Global Fund under a letter agreement to fund Wambo.org product purchases supporting HIV and malaria programs (place of performance: Switzerland), marking a State-channel contribution distinct from USAID’s bilateral global-health awards. (novelty: 3) (novelty: 3)
• 2021-03-12 — USAID · DELOITTE & TOUCHE LLP — $47.9M (KEN): USAID obligated $47.9M to Deloitte & Touche LLP for the Tujenge Jamii Activity (Kenya Health Partnerships for Quality Services), integrating HIV clinical, FP/RMNCAH, nutrition, and WASH services in Kenya. (novelty: 3)
• 2021-10-14 — USAID · MOI TEACHING AND REFERRAL HOSPITAL — $48.3M (KEN): USAID obligated $48.3M to Moi Teaching and Referral Hospital for the AMPATH UZIMA integrated activity in Kenya spanning HIV/AIDS clinical care, OVC, FP/RMNCAH, nutrition, and WASH, extending the global-health portfolio into a Kenyan public-hospital implementer. (novelty: 3)
• 2020-06-18 — USAID · MANAGEMENT SCIENCES FOR HEALTH, INC. — $49.2M (ETH): USAID obligated $49.2M to Management Sciences for Health, Inc. for the Eliminate Tuberculosis from Ethiopia program targeting TB, DR-TB, and TB/HIV service delivery, extending the global-health portfolio into Ethiopia TB control. (novelty: 3)
• 2021-06-09 — USAID · BAYLOR COLLEGE OF MEDICINE CHILDRENS FOUNDATION MALAWI — $66.3M (MWI): USAID obligated $66.3M to Baylor College of Medicine Children’s Foundation Malawi for comprehensive HIV treatment and care services in Malawi, expanding the Malawi HIV implementer portfolio alongside Partners in Hope and JHPIEGO. (novelty: 3)
• 2021-06-09 — USAID · PARTNERS IN HOPE — $69.3M (MWI): USAID obligated $69.3M to Partners in Hope for HIV treatment and care services in Malawi, adding to the Malawi global-health implementer portfolio alongside JHPIEGO. (novelty: 3)
• 2019-04-15 — USAID · PALLADIUM INTERNATIONAL LLC — $260.2M (USA): 2024 — USAID obligated $260.2M to Palladium International LLC for the Translating Data for Implementation (DFI) project supporting PEPFAR HIV epidemic-control data analysis and in-country health information systems (place of performance: USA). (novelty: 3)
• 2019-12-27 — USAID · JHPIEGO CORP — $281.9M (MWI): USAID obligated $281.9M to JHPIEGO CORP for technical and capacity assistance on maternal, newborn, and child health and family planning/reproductive health outcomes in Malawi. (novelty: 3)

Open questions

Related